FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Padagis US LLC)

View source ↗

Summary

FDA approved a supplemental application for bromocriptine mesylate (Padagis US LLC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Hyperprolactinemia
• Parkinson Disease
• Restless Legs Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• Bromocriptine mesylate (bromocriptine mesylate)

Snippet

SUPPL AP for BROMOCRIPTINE MESYLATE (BROMOCRIPTINE MESYLATE)